0% found this document useful (0 votes)
29 views7 pages

PATHOLOGY (Respiratory System) .

Obstructive lung disorders are characterized by increased airflow resistance, including conditions like COPD, asthma, bronchiectasis, and cystic fibrosis. Emphysema, a type of COPD, involves abnormal enlargement of airspaces and is primarily caused by smoking and α1-antitrypsin deficiency. Lung carcinoma is classified into non-small cell and small cell types, with various etiological factors including smoking and genetic mutations, presenting with symptoms like persistent cough and weight loss.

Uploaded by

6v54xgc8cx
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
29 views7 pages

PATHOLOGY (Respiratory System) .

Obstructive lung disorders are characterized by increased airflow resistance, including conditions like COPD, asthma, bronchiectasis, and cystic fibrosis. Emphysema, a type of COPD, involves abnormal enlargement of airspaces and is primarily caused by smoking and α1-antitrypsin deficiency. Lung carcinoma is classified into non-small cell and small cell types, with various etiological factors including smoking and genetic mutations, presenting with symptoms like persistent cough and weight loss.

Uploaded by

6v54xgc8cx
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

PATHOLOGY

1. Define & Classify Obstructive Lung Disorders

Definition:
Obstructive lung disorders are diseases characterized by increased
resistance to airflow due to partial or complete obstruction at any level from
the trachea to the respiratory bronchioles.
Classification:
1. Chronic Obstructive Pulmonary Disease (COPD):
• Emphysema
• Chronic bronchitis
2. Asthma
3. Bronchiectasis
4. Cystic Fibrosis (some sources include this)

EMPHYSEMA
2. Define & Classify Emphysema
Definition:
Emphysema is defined as abnormal permanent enlargement of airspaces
distal to the terminal bronchioles, accompanied by destruction of their
walls, without obvious fibrosis.
Classification (based on anatomic distribution):
1. Centriacinar (Centrilobular) – most common, involves
respiratory bronchioles (upper lobes), strongly associated with smoking.
2. Panacinar (Panlobular) – involves entire acinus, more common in
lower lobes; associated with α1-antitrypsin deficiency.
3. Paraseptal (Distal acinar) – affects distal alveoli, associated with
spontaneous pneumothorax in young adults.
4. Irregular Emphysema – acinus irregularly involved, usually
associated with scarring (asymptomatic, incidental finding).
3. Etiopathogenesis of Emphysema
Etiology:
• Cigarette Smoking – main cause (increased neutrophils,
macrophages, oxidative stress)
• α1-antitrypsin deficiency
• Environmental pollutants
Pathogenesis (Two major mechanisms):
1. Protease–Antiprotease Imbalance:• Neutrophils &
macrophages release proteases (elastase) which destroy alveolar walls.
• α1-antitrypsin neutralizes elastase; its deficiency leads to
unchecked tissue destruction.
2. Oxidative Stress:
• From smoke and inflammatory cells – inactivates antiproteases
and damages lung tissue
4. Clinical Features of Emphysema
• Progressive dyspnea (initially on exertion)
• Minimal cough, scanty sputum
• Barrel-shaped chest (hyperinflation)
• Use of accessory muscles of respiration
• “Pink puffers”: breathless, not cyanotic
• Weight loss due to increased work of breathing
• Prolonged expiration
• Complications: pneumothorax, pulmonary hypertension, cor
pulmonale
5. Morphology of Emphysema
Gross Features:
• Lungs appear large, voluminous, and pale
• Loss of normal sponginess
• Bulging of alveolar spaces
• Centriacinar type – more severe in upper lobes
• Panacinar type – more uniform involvement, lower lobes
Microscopy (Histology):
• Abnormally enlarged airspaces distal to terminal bronchioles
• Destruction of alveolar walls and septa
• Loss of capillary beds
• Thin, stretched alveolar walls (in early stages)
• No significant fibrosis
• Inflammatory infiltrates (macrophages, neutrophils)
• Pigment-laden macrophages (especially in smokers)⸻

2
LUNG CARCINOMA
Here’s a concise and structured answer based on Harsh Mohan and Robbins
Pathology textbooks regarding Lung Carcinoma (often asked in AP exams
like AP 15, AP 18):
a. Classification of Lung Carcinoma
Lung carcinomas are broadly classified into two major categories:
1. Non-Small Cell Lung Carcinoma (NSCLC) (~85% cases)
• Adenocarcinoma (most common overall, especially in non-
smokers)
• Squamous Cell Carcinoma
• Large Cell Carcinoma
2. Small Cell Lung Carcinoma (SCLC) (~15% cases)
New WHO classifications also recognize:
• Adenosquamous carcinoma
• Carcinoid tumors (typical & atypical)
• Large cell neuroendocrine carcinoma
• Sarcomatoid carcinomas
b. Etiopathogenesis & Clinical Features
Etiopathogenesis:
• Smoking: Strongest risk factor (esp. for SCLC & squamous cell
carcinoma)
• Environmental exposures:
• Radon gas, asbestos, air pollution
• Genetic mutations:
• Adenocarcinoma: EGFR, ALK, KRAS mutations
• SCLC: TP53, RB, MYC amplification
• Chronic inflammation: From COPD, pulmonary fibrosis
Clinical Features:
• Persistent cough, weight loss, hemoptysis
• Chest pain, dyspnea
• Hoarseness (recurrent laryngeal nerve involvement)
• Features of metastasis: Bone pain, CNS symptoms
• Often asymptomatic until advanced
c. Morphology
Gross:

3
• Squamous Cell Carcinoma: Central location, may cavitate
• Adenocarcinoma: Peripheral, firm gray-white mass
• Small Cell Carcinoma: Central, infiltrative, soft & friable
• Large Cell Carcinoma: Large, undifferentiated mass
Microscopy:
• Adenocarcinoma: Glandular differentiation, mucin production,
lepidic pattern (in situ)
• Squamous Cell Carcinoma: Keratin pearls, intercellular bridges
• Small Cell Carcinoma: Small cells, scant cytoplasm, nuclear
molding, high mitoses, necrosis
• Large Cell Carcinoma: Undifferentiated cells, no squamous or
glandular features
d. Complications & Paraneoplastic Syndromes
Complications:
• Local invasion: Pleura, pericardium, esophagus
• Superior vena cava syndrome
• Pancoast tumor: Invasion of apex causing Horner’s syndrome
• Effusions: Pleural or pericardial
• Metastasis: Liver, bone, brain, adrenals
Paraneoplastic Syndromes:
• SCLC:
• SIADH (→ hyponatremia)
• Cushing’s syndrome (ectopic ACTH)
• Lambert-Eaton Myasthenic Syndrome
• Squamous Cell Carcinoma:
• Hypercalcemia (PTHrP secretion)
• Others:
• Hypertrophic pulmonary osteoarthropathy
• Dermatomyositis

BRONCHIECTASIS
Here’s a concise, exam-ready summary of Bronchiectasis based on Harsh
Mohan and Robbins Pathologic Basis of Disease:
(a) Definition of Bronchiectasis
Bronchiectasis is a chronic necrotizing infection of the bronchi and
bronchioles leading to abnormal permanent dilation of these airways.

4
(b) Etiopathogenesis & Clinical Features
Etiopathogenesis:
Bronchiectasis results from a cycle of airway obstruction and chronic
infection, leading to destruction of the bronchial wall.
Predisposing conditions:
1. Obstruction (tumor, foreign body, mucus plugs)
2. Congenital/hereditary conditions:
• Cystic fibrosis (most common in children)
• Primary ciliary dyskinesia (e.g., Kartagener syndrome)
• Immunodeficiency states
3. Infections:
• Severe or necrotizing pneumonia (e.g., TB, Staphylococcus)
• Measles, pertussis
These factors impair mucociliary clearance, promoting infection and
inflammation, causing destruction and dilation of bronchi.
Clinical Features:
• Persistent productive cough with copious purulent sputum
• Hemoptysis
• Dyspnea and wheezing
• Clubbing of fingers in chronic cases
• Recurrent respiratory infections
• Worse in the morning due to postural drainage
(c) Morphology
Gross:
• Dilated bronchi extending to the pleural surface
• Commonly involves lower lobes, especially bilaterally
• Airways appear cystic or varicose
• Filled with foul-smelling purulent material
Microscopy:
• Destruction of bronchial walls
• Ulceration and necrosis of epithelium
• Acute and chronic inflammation
• Replacement by fibrous tissue (fibrosis)
• Squamous metaplasia or epithelial hyperplasia
(d) Complications
• Recurrent infections and abscesses

5
• Hemoptysis (sometimes massive)
• Amyloidosis (rare)
• Cor pulmonale due to pulmonary hypertension
• Respiratory failure
• Metastatic brain abscesses (from septic emboli)
Let me know if you’d like a diagram or mind map summarizing this.

NEOPLASIA
Definition of Neoplasia:
According to Harsh Mohan and Robbins Basic Pathology, neoplasia is
defined as:
“Neoplasia is the uncontrolled, abnormal proliferation of cells that persists
even after the removal of the stimulus which initiated the change.”
The resulting mass of abnormal cells is called a neoplasm or tumor.
The term is derived from Greek: neo = new, plasia = growth.
Salient Features of Neoplasia (as described in Harsh Mohan and Robbins):
1. Uncontrolled Cell Proliferation:
Neoplastic cells proliferate autonomously without regard to regulatory
signals, leading to persistent growth even in the absence of stimuli.
2. Clonality:
Neoplasms arise from a single progenitor cell that has undergone genetic
changes, making the tumor monoclonal in origin.
3. Genetic Alterations:
Neoplasms are the result of genetic mutations in proto-oncogenes, tumor
suppressor genes, apoptosis regulators, and DNA repair genes.
4. Loss of Differentiation (Anaplasia):
Malignant neoplasms often show a lack of cellular differentiation, with cells
appearing primitive and atypical.
5. Loss of Normal Regulatory Mechanisms:
Neoplastic cells evade normal growth controls (e.g., contact inhibition,
apoptosis), enabling limitless replication.
6. Formation of a Mass (Tumor):
Neoplasia usually leads to the formation of a mass or swelling due to the
accumulation of abnormal cells.

6
7. Autonomous Growth:
The growth of neoplastic cells continues without dependence on normal
growth signals or the presence of the original triggering factors.
8. Benign vs. Malignant Behavior:
• Benign tumors: Well-differentiated, slow-growing, non-invasive,
and localized.
• Malignant tumors: Poorly differentiated, fast-growing, invasive,
and capable of metastasis.
9. Invasion and Metastasis (Malignant Neoplasms):
A hallmark of malignancy is the ability to invade adjacent tissues and spread
to distant sites via blood, lymphatics, or body cavities.
10. Angiogenesis:
Neoplasms stimulate the formation of new blood vessels to support their
growth and survival.

You might also like